Business Insights, June 2010, Pages: 250
diseases).
Successful drugs and vaccines against infectious agents that put millions of people at risk have potentially lucrative markets. The key to developing those drugs is to understand the pathogenic
Venture Planning Group, Sep 2011, Pages: 650
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectiousdiseases and viruses, including
Frost & Sullivan, Nov 2010, Pages: 95
expenditure,” notes the analyst of this research. “The increased availability of low-cost generic drugs, paralleled by the rising incidence of infectiousdiseases in the country, will boost pharmaceutical
TriMark Publications, May 2011, Pages: 902
- Molecular Diagnostics in InfectiousDisease Testing
- Molecular Diagnostics Markets
Molecular Diagnostics in Cancer Testing
Molecular diagnostics is a rapidly-advancing area of research and medicine
Frost & Sullivan, Feb 2008, Pages: 224
-Anti-malarial
-Anti-TB drugs -1. InfectiousDisease Pharmaceutical Markets in Key Sub-Saharan African Countries
--1. Executive Summary
--2. Research Scope and Methodology
--3. Research Summary
Greystone Associates, May 2011
‘Transmucosal Drug Delivery: Markets & Prospects for Films, Sprays, Lozenges, Wafers & Tablets’ is a comprehensive evaluation and analysis of the technology, products and participants behind
Greystone Associates, May 2010
in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device
Venture Planning Group, Sep 2011
on performance, capabilities, goals and strategies of the leading players in the global infectiousdiseasedrug market.
- To help current suppliers realistically assess their financial, technological and marketing
Venture Planning Group, April 2010, Pages: 850
II. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW
A. MAJOR BLOOD TYPING, GROUPING & INFECTIOUSDISEASE SCREENING TESTS
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d
Global Markets Direct, Dec 2010, Pages: 28
institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by InfectiousDisease
Greystone Associates, Dec 2010
options
- Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets and prescribing decisions to 2014 Executive Summary
Inhaled Drug Delivery Market Dynamics
- Established
GlobalData, March 2011, Pages: 101
influenza, Ebola and Nipah virus have become a cause for concern globally.
In addition, the re-emergence of infectiousdiseases such tuberculosis and malaria in new and more dangerous forms that are drug
Decision Resources, Inc., Aug 2010, Pages: 73
therapies, immune and inflammatory disease therapies, infectiousdisease therapies, neurology drugs, psychiatric drugs, antineoplastic drugs, treatments for the side effects of chemotherapy, gastrointestinal
Takeda Pacific, Feb 2010, Pages: 144
This report is about the world market for biomarkers and tests used for drug R&D. The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases
Decision Resources, Inc., June 2010, Pages: 54
board-certified U.S. infectiousdisease specialists.
- Sources of funding for drug therapy: analysis of health insurance coverage for major viral diseases in the United States.
- Drug coverage patterns
Venture Planning Group, Dec 2011, Pages: 195
as extensive listings of companies developing or marketing new blood banking technologies and products.
Key topics covered:
- Blood Typing and Grouping Tests
- InfectiousDisease Screening Tests
-- AIDS
